Skip to main content
Top
Published in: Journal of Cancer Education 4/2015

01-12-2015

Challenges in Measuring Benefit of Clinical Research Training Programs—the ASH Clinical Research Training Institute Example

Authors: Lillian Sung, Mark Crowther, John Byrd, Scott D. Gitlin, Joe Basso, Linda Burns

Published in: Journal of Cancer Education | Issue 4/2015

Login to get access

Abstract

The American Society of Hematology developed the Clinical Research Training Institute (CRTI) to address the lack of training in patient-oriented research among hematologists. As the program continues, we need to consider metrics for measuring the benefits of such a training program. This article addresses the benefits of clinical research training programs. The fundamental and key components are education and mentorship. However, there are several other benefits including promotion of collaboration, job and advancement opportunities, and promotion of work-life balance. The benefits of clinical research training programs need to be measured so that funders and society can judge if they are worth the investment in time and resources. Identification of elements that are important to program benefit is essential to measuring the benefit of the program as well as program planning. Future work should focus on the constructs which contribute to benefits of clinical research training programs such as CRTI.
Literature
1.
go back to reference Lander B, Hanley GE, Atkinson-Grosjean J (2010) Clinician-scientists in Canada: barriers to career entry and progress. PLoS One 5(10):e13168 Lander B, Hanley GE, Atkinson-Grosjean J (2010) Clinician-scientists in Canada: barriers to career entry and progress. PLoS One 5(10):e13168
2.
go back to reference Shaywitz DA, Martin JB, Ausiello DA (2000) Patient-oriented research: principles and new approaches to training. Am J Med 109(2):136–140CrossRefPubMed Shaywitz DA, Martin JB, Ausiello DA (2000) Patient-oriented research: principles and new approaches to training. Am J Med 109(2):136–140CrossRefPubMed
3.
go back to reference Horn LV (2008) National Heart, Lung, and Blood Strategic Plan Training and Career Development Implementation Workgroup summary Horn LV (2008) National Heart, Lung, and Blood Strategic Plan Training and Career Development Implementation Workgroup summary
4.
go back to reference Varmus H (1997) Statement before Subcommittee on Public Health and Safety. National Cancer Institute of Health Varmus H (1997) Statement before Subcommittee on Public Health and Safety. National Cancer Institute of Health
5.
go back to reference Bakken LL, Lichtenstein M, Committee AE (2005) Survey of the impact of National Institutes of Health clinical research curriculum awards (K30) between 1999 and 2004. J Investig Med 53(3):123–127CrossRefPubMed Bakken LL, Lichtenstein M, Committee AE (2005) Survey of the impact of National Institutes of Health clinical research curriculum awards (K30) between 1999 and 2004. J Investig Med 53(3):123–127CrossRefPubMed
6.
go back to reference Gitlin SD, Yuan Z, Little RJ, Todd Iii RF (2005) Factors that influence successful training and faculty career development in hematology/oncology patient-oriented clinical research. J Cancer Educ 20(2):72–78CrossRefPubMed Gitlin SD, Yuan Z, Little RJ, Todd Iii RF (2005) Factors that influence successful training and faculty career development in hematology/oncology patient-oriented clinical research. J Cancer Educ 20(2):72–78CrossRefPubMed
7.
go back to reference Todd RF III, Gitlin SD, Burns LJ (2004) Committee on training programs: subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology. Blood 103(12):4383–4388CrossRefPubMed Todd RF III, Gitlin SD, Burns LJ (2004) Committee on training programs: subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology. Blood 103(12):4383–4388CrossRefPubMed
8.
go back to reference Strom BL, Norman S, Margolis DJ (2000) Patient-oriented research: definitions and new paradigms. Am J Med 109(2):164–165CrossRefPubMed Strom BL, Norman S, Margolis DJ (2000) Patient-oriented research: definitions and new paradigms. Am J Med 109(2):164–165CrossRefPubMed
9.
go back to reference Lipira L, Jeffe DB, Krauss M, Garbutt J, Piccirillo J, Evanoff B, Fraser V (2010) Evaluation of clinical research training programs using the clinical research appraisal inventory. Clin Transl Sci 3(5):243–248PubMedCentralCrossRefPubMed Lipira L, Jeffe DB, Krauss M, Garbutt J, Piccirillo J, Evanoff B, Fraser V (2010) Evaluation of clinical research training programs using the clinical research appraisal inventory. Clin Transl Sci 3(5):243–248PubMedCentralCrossRefPubMed
10.
go back to reference Dutcher JP (2011) Perceptions of patient oriented research among house staff and faculty in a clinically oriented internal medicine program. Clin Transl Sci 4(5):310–311CrossRefPubMed Dutcher JP (2011) Perceptions of patient oriented research among house staff and faculty in a clinically oriented internal medicine program. Clin Transl Sci 4(5):310–311CrossRefPubMed
11.
go back to reference Berk RA, Berg J, Mortimer R, Walton-Moss B, Yeo TP (2005) Measuring the effectiveness of faculty mentoring relationships. Acad Med 80(1):66–71CrossRefPubMed Berk RA, Berg J, Mortimer R, Walton-Moss B, Yeo TP (2005) Measuring the effectiveness of faculty mentoring relationships. Acad Med 80(1):66–71CrossRefPubMed
12.
go back to reference Rubio DM, Schoenbaum EE, Lee LS, Schteingart DE, Marantz PR, Anderson KE, Platt LD, Baez A, Esposito K (2010) Defining translational research: implications for training. Acad Med 85(3):470–475PubMedCentralCrossRefPubMed Rubio DM, Schoenbaum EE, Lee LS, Schteingart DE, Marantz PR, Anderson KE, Platt LD, Baez A, Esposito K (2010) Defining translational research: implications for training. Acad Med 85(3):470–475PubMedCentralCrossRefPubMed
Metadata
Title
Challenges in Measuring Benefit of Clinical Research Training Programs—the ASH Clinical Research Training Institute Example
Authors
Lillian Sung
Mark Crowther
John Byrd
Scott D. Gitlin
Joe Basso
Linda Burns
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2015
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0754-3

Other articles of this Issue 4/2015

Journal of Cancer Education 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine